Venaxis signs agreement with EMELCA Bioscience for E.U. launch of novel appendicitis test APPY1 Feb. 8, 2013
Agreement entered into on phase II trial of universal factor Xa inhibitor antidote PRT-4445 Feb. 6, 2013
RSS